v3.25.4
Income Taxes
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

13. Income taxes

Pretax loss consists of the following:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2025

 

 

2024

 

 

2023

 

United States

 

$

(7,854

)

 

$

(25,144

)

 

$

(57,779

)

Non-United States

 

 

(10,322

)

 

 

(871

)

 

 

(6,892

)

Total pretax loss

 

$

(18,176

)

 

$

(26,015

)

 

$

(64,671

)

 

 

The Companys components of the benefit (provision) for income taxes are as follows:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2025

 

 

2024

 

 

2023

 

Income tax benefit (provision)

 

 

 

 

 

 

 

 

 

Current:

 

 

 

 

 

 

 

 

 

Federal

 

$

0

 

 

$

0

 

 

$

0

 

State

 

 

(381

)

 

 

(582

)

 

 

16

 

Foreign

 

 

(536

)

 

 

(680

)

 

 

479

 

Total current

 

$

(917

)

 

$

(1,262

)

 

$

495

 

Deferred:

 

 

 

 

 

 

 

 

 

Federal

 

 

(109

)

 

 

(79

)

 

 

(579

)

State

 

 

(111

)

 

 

273

 

 

 

84

 

Foreign

 

 

(29

)

 

 

53

 

 

 

0

 

Total deferred

 

 

(249

)

 

 

247

 

 

 

(495

)

Total benefit (provision)

 

$

(1,166

)

 

$

(1,015

)

 

$

0

 

Total Federal

 

$

(109

)

 

$

(79

)

 

$

(579

)

Total State

 

$

(492

)

 

$

(309

)

 

$

100

 

Total Foreign

 

$

(565

)

 

$

(627

)

 

$

479

 

 

The Company’s provision for income taxes attributable to continuing operations differs from the expected tax expense (benefit) amount computed by applying the U.S. statutory federal income tax rate of 21 percent to income from continuing operations before income taxes. The variance is primarily a result of the application of a valuation allowance for net deferred assets, including NOL carryforwards and credits generated in Australia, the UK, and the United States. Current state income tax expense for the period is a result of the limitations of utilization of tax attributes in certain states due to legislative updated during the year. Current foreign income tax expense for the period is a result of taxable profits in Ireland, Ukraine and other foreign countries where the Company is profitable along with withholding taxes. Deferred income tax expense is a result of taxable temporary differences related to indefinite-lived assets.

Below is a tabular rate reconciliation pursuant to the disclosure requirement of ASU 2023-09 for the year ended December 31, 2025, 2024, and 2023:

 

 

 

Year ended December 31, 2025

 

 

Year ended December 31, 2024

 

 

Year ended December 31, 2023

 

 

(in thousands)

 

Amount

 

 

Percent

 

 

Amount

 

 

Percent

 

 

Amount

 

 

Percent

 

 

Loss before provision for income taxes

 

$

(18,176

)

 

 

100.00

 

%

$

(26,015

)

 

 

100.00

 

%

$

(64,671

)

 

 

100.00

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US Federal Statutory Tax Rate

 

 

(3,817

)

 

 

21.00

 

 

 

(5,463

)

 

 

21.00

 

 

 

(13,581

)

 

 

21.00

 

 

State & Local Income Taxes(1)

 

 

184

 

 

 

(1.01

)

 

 

(197

)

 

 

0.76

 

 

 

16

 

 

 

(0.02

)

 

Foreign Tax Effects

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Australia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

       Disallowed Stock Compensation

 

 

569

 

 

 

(3.13

)

 

 

872

 

 

 

(3.35

)

 

 

842

 

 

 

(1.30

)

 

       Statutory Tax Rate Difference

 

 

(530

)

 

 

2.91

 

 

 

373

 

 

 

(1.43

)

 

 

0

 

 

 

0.00

 

 

       Return to Provision Adjustment

 

 

0

 

 

 

0.00

 

 

 

378

 

 

 

(1.45

)

 

 

0

 

 

 

0.00

 

 

       Change in Valuation Allowance

 

 

1,496

 

 

 

(8.23

)

 

 

(2,769

)

 

 

10.64

 

 

 

(1,770

)

 

 

2.74

 

 

       R&D Tax Credit

 

 

(297

)

 

 

1.63

 

 

 

0

 

 

 

0.00

 

 

 

1,246

 

 

 

(1.93

)

 

       Other

 

 

122

 

 

 

(0.67

)

 

 

400

 

 

 

(1.54

)

 

 

(172

)

 

 

0.27

 

 

    United Kingdom

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

       Change in Valuation Allowance

 

 

1,421

 

 

 

(7.82

)

 

 

1,444

 

 

 

(5.55

)

 

 

2,067

 

 

 

(3.20

)

 

       Foreign Rate Differential

 

 

(231

)

 

 

1.27

 

 

 

0

 

 

 

0.00

 

 

 

0

 

 

 

0.00

 

 

       Other

 

 

49

 

 

 

(0.27

)

 

 

(196

)

 

 

0.75

 

 

 

(303

)

 

 

0.47

 

 

    Other Foreign Jurisdictions

 

 

118

 

 

 

(0.65

)

 

 

335

 

 

 

(1.29

)

 

 

34

 

 

 

(0.05

)

 

Effects of Changes in Tax Law

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effects of Cross-Border Tax Laws

 

 

64

 

 

 

(0.35

)

 

 

387

 

 

 

(1.49

)

 

 

31

 

 

 

(0.05

)

 

Tax Credits - R&D

 

 

(826

)

 

 

4.54

 

 

 

(1,966

)

 

 

7.56

 

 

 

(2,841

)

 

 

4.39

 

 

Changes in Valuation Allowances

 

 

(924

)

 

 

5.09

 

 

 

(10,474

)

 

 

40.28

 

 

 

11,329

 

 

 

(17.51

)

 

Nontaxable or Nondeductible Items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Officer's Compensation

 

 

482

 

 

 

(2.65

)

 

 

412

 

 

 

(1.58

)

 

 

684

 

 

 

(1.06

)

 

    Share-Based Payments

 

 

2,340

 

 

 

(12.87

)

 

 

4,359

 

 

 

(16.76

)

 

 

4,042

 

 

 

(6.25

)

 

    Effects of Debt Exchange

 

 

0

 

 

 

0.00

 

 

 

1,667

 

 

 

(6.41

)

 

 

0

 

 

 

0.00

 

 

    Other

 

 

275

 

 

 

(1.51

)

 

 

400

 

 

 

(1.54

)

 

 

198

 

 

 

(0.31

)

 

Changes in Unrecognized Tax Benefits

 

 

167

 

 

 

(0.92

)

 

 

8,761

 

 

 

(33.69

)

 

 

0

 

 

 

0.00

 

 

Business Combination Impact

 

 

0

 

 

 

0.00

 

 

 

0

 

 

 

0.00

 

 

 

(785

)

 

 

1.21

 

 

Other - Return to Provision Adjustment and True-Ups

 

 

(389

)

 

 

2.14

 

 

 

1,515

 

 

 

(5.82

)

 

 

(1,920

)

 

 

2.97

 

 

Imputed Interest

 

 

893

 

 

 

(4.91

)

 

 

777

 

 

 

(2.99

)

 

 

883

 

 

 

(1.37

)

 

Effective tax rate

 

$

1,166

 

 

 

(6.41

)

%

$

1,015

 

 

 

(3.90

)

%

$

0

 

 

 

0.00

 

%

(1) The states that contribute to the majority (greater than 50 percent) of the tax effect on this category include California and Texas for fiscal year 2025 and 2024. For fiscal year 2023, Texas is the only state that contributed to the majority of the tax effect on this category.

The Company's effective tax rate for the year ended December 31, 2025, was (6.41)%, compared to the U.S. federal statutory rate of 21%. The primary factors driving the difference between the statutory and effective tax rates are as follows:

Stock-Based Compensation: The disallowance of certain stock-based compensation expenses increased tax expense and changed the effective tax rate by 16.00%, reflecting the impact of non-deductible stock-based compensation expense.
Changes in Valuation Allowance: The Company decreased portions of its valuation allowance on deferred tax assets, which reduced the effective tax rate by (10.96)%. This release was based on an assessment of the Company’s ability to utilize certain deferred tax assets in future periods.
Research and Development (R&D) Tax Credits: The Company generated federal and state research and development tax credits, which increased the effective tax rate by 6.02%.
State Income Taxes, Net of Federal Benefit: State income taxes, net of the federal benefit, decreased the effective tax rate by (1.01)%, reflecting the impact of state tax obligations on taxable income.

 

Other immaterial reconciling items contributed to the remaining difference between the statutory and effective tax rates.

Income taxes paid, net of refunds, during the year ended December 31, 2025, 2024, and 2023 were as follows:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2025

 

 

2024

 

 

2023

 

Jurisdiction:

 

 

 

 

 

 

 

 

 

United States - Federal

 

$

30

 

 

$

0

 

 

$

0

 

United States - State and Local

 

 

224

 

 

 

48

 

 

 

28

 

Ireland

 

 

0

 

 

 

0

 

 

 

61

 

Mexico

 

 

166

 

 

 

157

 

 

 

310

 

Poland

 

 

68

 

 

 

0

 

 

 

0

 

Spain

 

 

45

 

 

 

0

 

 

 

0

 

Ukraine

 

 

62

 

 

 

72

 

 

 

87

 

United Kingdom

 

 

126

 

 

 

100

 

 

 

83

 

All Other Foreign Jurisdictions

 

 

54

 

 

 

4

 

 

 

14

 

Total Income Taxes Paid

 

$

775

 

 

$

381

 

 

$

583

 

Of the $0.2 million of United States state and local taxes paid during the fiscal year 2025, payments to the states of Minnesota, New York, and Texas accounted for greater than 50 percent of the total taxes paid.

The One Big Beautiful Bill Act ("OBBBA") was enacted in the U.S. effective July 4, 2025. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. OBBBA has multiple effective dates, with certain provisions effective in fiscal 2025 and others implemented through fiscal 2027. The Company accounted for the effects of OBBBA on the Company's tax provision for the year ended December 31, 2025, which was determined to be immaterial. While further evaluation is ongoing, the OBBBA is not expected to have a material impact on the Company's balance sheet, statement of operations, or cash flows.

The Tax Cuts and Jobs Act of 2017 (the “TJCA”) subjects a U.S. shareholder to current tax on certain earnings of foreign subsidiaries under a provision commonly known as the global intangible low-taxed income (“GILTI”). Under U.S. GAAP, an accounting policy election can be made to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years, or to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense only. The Company has elected to account for GILTI in the year the tax is incurred.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

Significant components of the Company’s deferred tax assets and liabilities are as follows:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2025

 

 

2024

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss and credit carryforwards

 

$

93,868

 

 

$

86,433

 

Accrued compensation

 

 

1,335

 

 

 

1,613

 

Allowance for credit losses

 

 

1,008

 

 

 

709

 

Capitalized research and experimental costs

 

 

21,785

 

 

 

24,699

 

Deferred lease liabilities

 

 

2,008

 

 

 

1,100

 

Deferred revenue

 

 

32

 

 

 

106

 

Depreciation and amortization

 

 

20,629

 

 

 

20,871

 

Stock-based compensation

 

 

3,503

 

 

 

3,854

 

Debt related items

 

 

3,434

 

 

 

4470

 

Other

 

 

85

 

 

 

108

 

Gross deferred tax assets

 

$

147,687

 

 

$

143,963

 

Valuation allowance

 

 

(139,958

)

 

 

(136,536

)

Deferred tax liabilities:

 

 

 

 

 

 

Deferred commissions

 

 

(2,042

)

 

 

(3,018

)

Right-of-use assets

 

 

(1,661

)

 

 

(565

)

Goodwill

 

 

(2,906

)

 

 

(2,275

)

Prepaid expenses

 

 

(2,008

)

 

 

(2,016

)

Other

 

 

(75

)

 

 

(267

)

Gross deferred tax liabilities

 

$

(8,692

)

 

$

(8,141

)

Net deferred tax liabilities

 

$

(963

)

 

$

(714

)

 

The Company has determined it is more likely than not that its deferred tax assets will not be realized based on the Company's lack of earnings history. Accordingly, it has provided a valuation allowance for deferred tax assets. During 2025, the valuation allowance increased by approximately $1.4 million due to continuing operations as well as reserves that were established against certain R&D tax credits.

At December 31, 2025, the Company had net operating loss (“NOL”) carryforwards for U.S. federal income tax purposes of approximately $256.1 million. Of this total, $255.7 million is related to tax years 2018-2024 that do not have an expiration, as a result of the TCJA. The remaining $0.4 million of U.S. federal NOL carryforwards are available to offset future U.S. federal taxable income and begin to expire in 2036.

At December 31, 2025, the Company had NOL carryforwards for certain state income tax purposes of approximately $150.0 million. These state NOL carryforwards are available to offset future state taxable income and begin to expire in 2036.

At December 31, 2025, the Company had foreign NOL carryforwards in Australia and the U.K., combined, of approximately $59.0 million, which are available to offset future foreign taxable income and that do not have an expiration.

At December 31, 2025, the Company had research and development tax credit carryforwards of approximately $15.7 million, which are available to offset future U.S. federal income tax. These U.S. federal tax credits begin to expire in 2034.

Our ability to utilize previously accumulated NOL and R&D credit carryforwards may be subject to substantial annual limitations due to the changes in ownership provisions of the Internal Revenue Code (IRC) of 1986, as amended, and similar state regulations as defined in IRC Section 382(g). In general, the annual limitation is equal to the value of our stock immediately before the ownership change, multiplied by the long-term tax-exempt rate for the month in which the ownership change occurred. Any unused annual limitation may generally be carried over to later years until the NOL carryforwards expire.

At December 31, 2025, the Company did not provide any U.S. income or foreign withholding taxes related to certain foreign subsidiaries’ undistributed earnings, as such earnings have been retained and are intended to be indefinitely reinvested. The majority of the Company’s foreign operations are in excess tax basis over book basis positions. It is not practicable to estimate the amount of taxes that would be payable upon remittance of these earnings, because such tax, if any, is dependent upon circumstances existing if and when remittance occur.

The Company files U.S. federal, state and foreign income tax returns in jurisdictions with varying statutes of limitations. The 2021 through 2025 tax years generally remain open and subject to examination by U.S. federal, state and foreign tax authorities. Losses

generated in any year since inception remain open to adjustment until the statute of limitations closes for the tax year in which the NOL carryforwards are utilized.

As of December 31, 2025, 2024, and 2023, the Company had $10.3 million, $9.8 million, and $0.4 million unrecognized tax benefits, respectively, none of which may reverse in the next 12 months. The Company’s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. During 2025, 2024, and 2023, the Company did not recognize any material interest or penalties.

A reconciliation of the Company's liability for unrecognized tax benefits is as follows:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2025

 

 

2024

 

 

2023

 

Balance, beginning of year

 

$

9,766

 

 

$

396

 

 

$

396

 

Increase for tax positions related to the current year

 

 

573

 

 

 

797

 

 

 

0

 

Increase for tax positions related to the prior years

 

 

0

 

 

 

8,573

 

 

 

0

 

Decrease for tax positions related to prior years

 

 

0

 

 

 

0

 

 

 

0

 

Balance, end of year

 

$

10,339

 

 

$

9,766

 

 

$

396